ARCT Q3 2020 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$210M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-29.7% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$21M-897.5% margin

Net Income

-$21M-900.3% margin

EPS (Diluted)

$-0.92

QoQ Revenue Growth

+0.5%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$323M

Total Liabilities

$61M

Stockholders' Equity

$262M

Cash & Equivalents

$307M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-29.7%
Gross Profit	$2M	-$4M	+162.5%
Operating Income	-$21M	-$8M	-174.9%
Net Income	-$21M	-$7M	-182.6%